Trademark Overview
On Thursday, August 1, 2024, a trademark application was filed for XERISOL with the United States Patent and Trademark Office. The USPTO has given the XERISOL trademark a serial number of 98677670. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, November 7, 2024. This trademark is owned by Xeris Pharmaceuticals, Inc.. The XERISOL trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of diseases and conditions, namely, alimentary tract, metabolic, oncologic, autoimmune, and nervous system diseases and conditions; pharmaceutical preparations for the treatment of diseases and conditions, namely, anti-invectives to prevent or treat infections, vaccines, antineoplastic pharmaceutical preparations for the treatment of cancer, and immunomodulating pharmaceutical preparations for the treatment of immune system related diseases and disorders